摘要
目的:探讨头孢噻肟,头孢曲松等6种头孢菌素治疗儿童肺炎的成本-效果。方法:采用回顾性研究和成本-效果分析方法,对儿童肺炎成本进行药物经济学评价。结果:在达到基本一致(P>0.05)的治疗效果时,头孢噻肟、头孢曲松、头孢哌酮的成本及成本-效果较低,其余3种头孢菌素的这两项指标均有大幅提高。结论:与其他5种头孢菌素比较,用头孢曲松治疗儿童肺炎具有费用适中,成本-效果比及ADR发生率较低等优点。
Objective: To compare the cost-effectiveness of children's pneumonia treated with six kinds cephalosporins such as ce-fotaxime, ceftriaxone et al. Methods: pharmacoeconomics of treating children's pneumonia was appraised pneumonia, by retrospective study and cost -effectiveness analysis. Result: The costs cost-effectiveness of cefotaxime, ceftriaxone and cefoperazone are smaller than that of rest three kinds of cephalosporins, which had increased argely, when the curative effect was at identical essentially( P > 0.05). Conclusion: The cost-effectiveness of children' s pneumonia treated with ceftriaxone is superior than the other five cephalosporins, and its ADR occrrence is lower than those.
出处
《中国药师》
CAS
2002年第11期674-675,共2页
China Pharmacist
